Received in the Senate and referred to the Committee on Health, Education, Labor, and Pensions.
This resolution expresses Congresss support for designating September as Sickle Cell Disease Awareness Month and encourages awareness, research, and services related to sickle cell disease. It is a formal statement of opinion and concern, not a law, and does not create new legal rights or obligations. It asks people and organizations to promote education and research but does not require any government action.
Concurrent resolutions are adopted by both the House and the Senate but are not sent to the President and do not have the force of law. They are used for statements of position, to coordinate between the chambers, or to direct internal congressional actions.
This concurrent resolution expresses Congress's support for designating September as Sickle Cell Disease Awareness Month.
It summarizes sickle cell disease statistics, notes treatment and research needs, recognizes the Sickle Cell Disease Association of America, and supports awareness, research, and prevention efforts.
Concurrent resolutions do not create law; passage in both chambers possible but it cannot become statute.
Relative to its intended legislative type, this bill is a well-constructed symbolic/concurrent resolution: it provides a clear statement of purpose and supporting factual context appropriate to designating Sickle Cell Disease Awareness Month, and it contains the limited mechanism expected for such a resolution (an expression of support).
Symbolic recognition versus demand for concrete funding
These are examples from the analysis, not a ranked list of the most-affected groups.
Symbolic recognition versus demand for concrete funding
Likely views the resolution positively as recognition of a racial health disparity and a call for research, screening, and care access.
Sees it as a useful awareness step but insufficient without funding and concrete policy follow-through.
Likely supportive of a non-binding awareness resolution while wanting clear, measurable outcomes.
Appreciates bipartisan recognition but prefers follow-up steps with cost estimates and oversight.
Generally inclined to accept a resolution supporting awareness, but cautious about federal involvement and potential spending pressures.
Prefers private, state, and nonprofit solutions over new federal mandates.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Concurrent resolutions do not create law; passage in both chambers possible but it cannot become statute.
The bill has not accumulated any surfaced votes yet.
Symbolic recognition versus demand for concrete funding
Concurrent resolutions do not create law; passage in both chambers possible but it cannot become statute.
Relative to its intended legislative type, this bill is a well-constructed symbolic/concurrent resolution: it provides a clear statement of purpose and supporting factual context appropriate to designating Sickle Cell D…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.